Skip to main content

Table 1 SHCS Patient Characteristics

From: Immunophenotypic characterization of TCR γδ T cells and MAIT cells in HIV-infected individuals developing Hodgkin’s lymphoma

  HIV+ w/o HL group (n = 10) HIV+ HL+ group (n = 10) w/o HL vs. HL+ (p-value)
Gender
 Male 10 10 NA
Ethnicity
 Caucasian 10 10 NA
Age at HIV diagnosis, median (IQR) 34.5 (28.75, 38) 31 (26.75, 39) 0.1211
Baseline plasma viral load (copies per ml), median (IQR) 25,865 (11,730, 51,475) 24,092 (14,550, 739,500) 0.1602
Baseline CD4+ T cell count per ul, median (IQR) 523 (368, 602) 448 (310, 526) 0.3750
Years between HIV diagnosis and initiation of cART, median (IQR) 3 (1.5, 3.25) 2 (0, 2.5) 0.4688
Duration cART in days, median (IQR) 976 (717, 1457) 1382 (568, 2328) 0.3750
cART included EFV (%) 30% 60% 0.3698i
Age at HL diagnosis,
median (IQR)
NA 39 (34, 44.25)  
  1. Abbreviations: cART combined antiretroviral therapy, HL Hodgkin’s lymphoma, EFV Efavirenz
  2. Statistical analysis: Wilcoxon signed-rank test and iexact Fisher’s test